Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip Janku

Showing results (21-30 of 277) with videos related to

Pageof 28
Sort By:
Nature Reviews. Clinical Oncology|June 17, 2010
Targeted therapy in non-small-cell lung cancer--is it becoming a reality?Filip Janku, David J Stewart, Razelle Kurzrock
Journal of Medical Case Reports|April 18, 2015
Castleman's disease and sarcoidosis, a rare association resulting in a "mixed" response: a case reportAnwarullah Mohammed, Filip Janku, Ming Qi, et al.
The Oncologist|January 10, 2013
A tale of two histiocytic disordersFilip Janku, Javier Munoz, Vivek Subbiah, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 17, 2005
Symptomatic control of hypoglycaemia with prednisone in refractory metastatic pancreatic insulinomaJan Novotny, Filip Janku, Pavel Mares, et al.
Nature Reviews. Clinical Oncology|March 7, 2018
Targeting the PI3K pathway in cancer: are we making headway?Filip Janku, Timothy A Yap, Funda Meric-Bernstam
JAMA Oncology|November 13, 2018
Moving Precision Oncology Forward Amid Myths and MisconceptionsFilip Janku, Kenneth R Hess, Timothy A Yap
Trends in Genetics : TIG|October 10, 2015
Accessing Genetic Information with Liquid BiopsiesXuyu Cai, Filip Janku, Qimin Zhan, et al.
Current Problems in Cancer|April 19, 2017
Circulating tumor DNA-From bench to bedsideJoline S J Lim, Filip Janku, Timothy A Yap
Mayo Clinic Proceedings|May 13, 2014
Erdheim-Chester disease: characteristics and managementJavier Munoz, Filip Janku, Philip R Cohen, et al.
Nature Reviews. Clinical Oncology|May 19, 2011
Autophagy as a target for anticancer therapyFilip Janku, David J McConkey, David S Hong, et al.
Pageof 28

Showing results (21-30 of 277) with videos related to

Sort By:
Pageof 28
Nature Reviews. Clinical Oncology|June 17, 2010
Targeted therapy in non-small-cell lung cancer--is it becoming a reality?Filip Janku, David J Stewart, Razelle Kurzrock
Journal of Medical Case Reports|April 18, 2015
Castleman's disease and sarcoidosis, a rare association resulting in a "mixed" response: a case reportAnwarullah Mohammed, Filip Janku, Ming Qi, et al.
The Oncologist|January 10, 2013
A tale of two histiocytic disordersFilip Janku, Javier Munoz, Vivek Subbiah, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 17, 2005
Symptomatic control of hypoglycaemia with prednisone in refractory metastatic pancreatic insulinomaJan Novotny, Filip Janku, Pavel Mares, et al.
Nature Reviews. Clinical Oncology|March 7, 2018
Targeting the PI3K pathway in cancer: are we making headway?Filip Janku, Timothy A Yap, Funda Meric-Bernstam
JAMA Oncology|November 13, 2018
Moving Precision Oncology Forward Amid Myths and MisconceptionsFilip Janku, Kenneth R Hess, Timothy A Yap
Trends in Genetics : TIG|October 10, 2015
Accessing Genetic Information with Liquid BiopsiesXuyu Cai, Filip Janku, Qimin Zhan, et al.
Current Problems in Cancer|April 19, 2017
Circulating tumor DNA-From bench to bedsideJoline S J Lim, Filip Janku, Timothy A Yap
Mayo Clinic Proceedings|May 13, 2014
Erdheim-Chester disease: characteristics and managementJavier Munoz, Filip Janku, Philip R Cohen, et al.
Nature Reviews. Clinical Oncology|May 19, 2011
Autophagy as a target for anticancer therapyFilip Janku, David J McConkey, David S Hong, et al.
Pageof 28